cancer

ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
Pharmaforum
Fri, 06/5/20 - 10:30 am
ASCO 2020
Amgen
AstraZeneca
Bristol-Myers Squibb
cancer
CAR-T
COVID-19
Keytruda
Kyprolis
Tagrisso
AstraZeneca puts $55M into Accent as pharmas continue push to drug RNA
BioPharma Dive
Thu, 06/4/20 - 11:17 am
AstraZeneca
Accent Therapeutics
cancer
RNA
COVID-19 could slow progress in reducing cancer death, NCI head warns
Biopharma Dive
Mon, 06/1/20 - 10:36 am
cancer
cancer deaths
COVID-19
NCI
pandemic
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO
Xconomy
Sat, 05/30/20 - 08:02 pm
cancer
IPOs
Repare Therapeutics
Bristol-Myers Squibb
ASCO 2020 virtual annual meeting – day 1 (live updates)
Pharmaforum
Fri, 05/29/20 - 12:39 pm
ASCO 2020
virtual meetings
oncology
cancer
COVID-19
pandemic
J&J, AbbVie, Roche and more sponsor cancer content for concerned patients amid COVID-19 pandemic
Fierce Pharma
Tue, 05/19/20 - 11:27 pm
cancer
JNJ
AbbVie
Roche
pharma advertising
oncology
ADC Therapeutics sets IPO terms, to be valued at up to $1 billion
Marketwatch
Fri, 05/15/20 - 11:02 am
ADC Therapeutics
IPOs
cancer
Switzerland
How the pandemic helped secure a rare cancer drug for Menarini
Endpoints
Thu, 05/14/20 - 11:53 am
cancer
Menarini
Stemline
COVID-19
pandemic
Elzonris
AML
A groundbreaking cancer drug nabs fast OK, giving Eli Lilly boasting rights as a rival speeds close behind
Endpoints
Sun, 05/10/20 - 09:30 pm
Eli Lilly
selpercatinib
Retevmo
FDA
cancer
Loxo Oncology
Blueprint Medicines
Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs
Xconomy
Fri, 05/8/20 - 10:30 am
Ayala Pharmaceuticals
IPOs
cancer
Bristol-Myers Squibb
Macrogenics scoops its ASCO bounce
EP Vantage
Fri, 05/8/20 - 10:20 am
ASCO 2020
Macrogenics
margetuximab
cancer
breast cancer
gastric cancer
Blood test for cancer detection company Grail rakes in $390M in latest round
Endpoints
Thu, 05/7/20 - 10:47 am
diagnostics
Grail
oncology
cancer
Another delay for Bristol Myers cell therapy as FDA extends review
BioPharma Dive
Wed, 05/6/20 - 12:21 pm
FDA
Bristol-Myers Squibb
liso-cell
cancer
cell therapy
Oncology biotech Ayala Pharmaceuticals sets terms for $50 million IPO
NASDAQ
Mon, 05/4/20 - 10:41 am
Ayala Pharmaceuticals
Israel
small molecule drugs
cancer
IPOs
Will Last Week's Biotech IPO Outperform in a Recession?
Motley Fool
Tue, 04/28/20 - 10:46 am
IPOs
ORIC Pharmaceuticals
cancer
oncology
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today
Motley Fool
Tue, 04/21/20 - 12:07 am
Clovis Oncology
Immunomedics
Puma Biotechnology
cancer
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer
Xconomy
Wed, 04/15/20 - 10:38 am
PIC Therapeutics
Harvard
cancer
oncology
Micro-cap Mei Pharma lands $100M upfront on beleaguered PI3K pathway
Endpoints
Tue, 04/14/20 - 10:03 am
MEI Pharma
cancer
PI3k inhibitor
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs
Xconomy
Thu, 04/9/20 - 10:28 am
Tango Therapeutics
CRISPR
cancer
drug development
Zentalis Pharmaceuticals Raises $165 Million in Expanded IPO
Bloomberg
Fri, 04/3/20 - 11:20 am
Zentalis
cancer
oncology
IPOs

Pages